RxDoctor Payments Data

Rebecca Gleason

Psychiatric/Mental Health · Flint, MINPI 1972936938

Payments from drug & device makers

$2,786in general payments, 2019–2025

Across 155 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$835
  • Otsuka America Pharmaceutical, Inc.$574
  • E.r. Squibb & Sons, L.L.C.$207
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$203
  • Teva Pharmaceuticals USA, Inc.$170
  • AbbVie$149
  • plus $649 from 11 others

What the payments were for

  • Food & beverage$2,786100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,786 in reported general payments places this provider in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$12,696
Medicare patients
51
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate60$218,056
AustedoDeutetrabenazine12$87,804
RexultiBrexpiprazole15$21,750
TrintellixVortioxetine Hydrobromide89$19,501
Aripiprazole157$12,498
Paliperidone ErPaliperidone29$5,346
Divalproex Sodium ErDivalproex Sodium89$4,628
Atomoxetine Hcl37$3,523
Clozapine41$3,503
Lurasidone Hcl73$3,346
Divalproex Sodium132$2,974
Chlorpromazine Hcl14$2,634
Haloperidol59$2,597
Oxcarbazepine41$2,135
Quetiapine Fumarate ErQuetiapine Fumarate68$1,870

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$149$218,05660 claims
Teva Pharmaceuticals USA, Inc.Austedo$170$87,80412 claims
Otsuka America Pharmaceutical, Inc.Rexulti$574$21,75015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →